Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease
{{output}}
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects ~40% of adults, but causal mechanisms remain elusive. Preclinical models implicate the gut microbiota in MASLD pathogenesis, yet translation to ... ...
